Jennifer Liedel
University of Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jennifer Liedel.
Critical Care Medicine | 2001
Paul E. Wischmeyer; James P. Lynch; Jennifer Liedel; Rachel K. Wolfson; Jacob Riehm; Lawrence J. Gottlieb; Madelyn Kahana
Objective To determine the effect of intravenous glutamine supplementation vs. an isonitrogenous control on infectious morbidity in severely burned patients. Previous clinical studies in seriously ill patients suggest a beneficial effect of glutamine on infectious morbidity, but no trials have examined possible clinical benefits in severely burned patients. Design Prospective, double-blind, randomized trial. Setting Burn intensive care unit of a university hospital. Patients Twenty-six severe burn patients with total burn surface area of 25% to 90% and presence of full-thickness burns. Patients were evaluated for occurrence of bacteremia and antibiotic use during the first 30 days of their burn unit admission. Nutritional status and overall inflammation were also measured. Intervention Either intravenous glutamine or an isonitrogenous control amino acid solution was administered as a continuous infusion during burn intensive care unit stay. Measurements and Main Results The incidence of Gram-negative bacteremia was significantly reduced in the glutamine-supplemented group (8%) vs. control (43%;p < .04). No difference was seen in the incidence of Gram-positive bacteremia or fungemia. Average number of positive blood cultures, antibiotic usage, and mortality rates also were reduced but did not reach statistical significance. Significant improvements in serum transferrin and prealbumin were observed in glutamine-supplemented patients at 14 days after burn injury (p < .01 and .04, respectively). C-reactive protein was also significantly reduced at 14 days after burn injury in the glutamine group (p < .01). Conclusions Significantly fewer bacteremic episodes with Gram-negative organisms occurred in the glutamine-supplemented patients. Glutamine supplementation improved measures of nutrition and decreased measures of overall inflammation. In addition, a trend toward lower mortality rate, decreased overall bacteremia incidence, and antibiotic usage in the glutamine group was observed. Glutamine’s beneficial effects may be a result of improved gut integrity or immune function, but the precise mechanism of glutamine’s protection is unknown.
Pediatric Research | 2011
Jennifer Liedel; Yuee Guo; Yueyue Yu; Sheng Ru Shiou; Sangzi Chen; Elaine O. Petrof; Shien Hu; Mark W. Musch; Erika C. Claud
Preterm infants face many challenges in transitioning from the in utero to extrauterine environment while still immature. Failure of the preterm gut to successfully mature to accommodate bacteria and food substrate leads to significant morbidity such as neonatal necrotizing enterocolitis. The intestinal epithelial barrier plays a critical role in gut protection. Heat shock protein 70 (Hsp70) is an inducible cytoprotective molecule shown to protect the intestinal epithelium in adult models. To investigate the hypothesis that Hsp70 may be important for early protection of the immature intestine, Hsp70 expression was evaluated in intestine of immature rat pups. Data demonstrate that Hsp70 is induced by exposure to mothers milk. Hsp70 is found in mothers milk, and increased Hsp70 transcription is induced by mothers milk. This Hsp70 colocalizes with the tight junction protein ZO-1. Mothers milk-induced Hsp70 may contribute to maintenance of barrier function in the face of oxidant stress. Further understanding of the means by which mothers milk increases Hsp70 in the ileum will allow potential means of strengthening the intestinal barrier in at-risk preterm infants.
Critical Care Medicine | 2015
Mark Shlomovich; Michael Miksa; Jacqueline Weingarten-Arams; Jennifer Liedel
Crit Care Med 2015 • Volume 43 • Number 12 (Suppl.) She met 6 of 8 criteria for HLH (fever, splenomegaly, cytopenia, hemophagocytosis in bone marrow, elevated serum ferritin and soluble interleukin-2 receptor levels) and was treated with high dose steroids and etoposide. She made gradual recovery and was discharged home 3 weeks later. An uncontrolled hypercytokinemia complicates differentiation of HLH from severe sepsis. However, early investigations can facilitate diagnosis and aggressive treatment of HLH with good outcome.
Critical Care Medicine | 2016
Shubhi Kaushik; Shivanand Medar; Michael Miksa; Jennifer Liedel; Jacqueline Weingarten-Arams
Critical Care Medicine | 2015
Santosh Kaipa; Chhavi Katyal; Jennifer Liedel
Critical Care Medicine | 2015
Neha Longani; Jennifer Liedel
Critical Care Medicine | 2014
Prakadeshwari Rajapreyar; Nathan P. Heinzerling; Deborah L. Donohoe; David M. Gourlay; Jennifer Liedel
Critical Care Medicine | 2006
Naomi Laventhal; Jennifer Liedel; Melody Taboada; Madelyn Kahana
Critical Care Medicine | 2006
Jennifer Liedel; Rebecca A Nolan; Madelyn Kahana; Bassem N. Mora
Critical Care Medicine | 2004
Jennifer Liedel; Madelyn Kahana